Pharma Journalist -

CENTOGENE announced a clinical development collaboration with Orphazyme A/S to improve the lives of patients and families living with neuronopathic Gaucher disease, a rare, inherited,…
Read More...

mAbxience, a company specialized in the research, development, manufacturing and global commercialization of monoclonal antibody biosimilars, part of the Insud Pharma Group and Amneal…
Read More...

Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute of Technology Center for…
Read More...

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the European Commission has…
Read More...

Takeda Pharmaceutical Company Limited announced it has entered into an agreement to sell its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma Co (Techpool), a leader in…
Read More...

Evotec AG announced today that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in…
Read More...

Avenue Therapeutics announced that its first pivotal Phase 3 trial of IV tramadol achieved the primary endpoint of a statistically significant improvement in Sum of Pain Intensity…
Read More...

Dova Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has completed their Priority Review and approved DOPTELET (avatrombopag) for the treatment of…
Read More...

Harmony Biosciences announced that it has received Breakthrough Therapy and Fast Track designations for its investigational product, pitolisant, from the U.S. Food and Drug…
Read More...

Thermo Fisher Scientific announced Astex Pharmaceuticals selected the Thermo Scientific Glacios Cryo Transmission Electron Microscope (Cryo-TEM) to aid in its drug discovery and…
Read More...